Riskpilot← Back to searchSign inGet full accessTER REK AS
ASActiveOrg 814163792Olav Selvaags Plass 4, 0252 OsloRetail sale of other food · NACE 4727Est. 20140 employees
Revenue 2024
NOK 525K
+18% vs 2023
EBITDA margin
73.3%
+22% vs 2023
Equity ratio
98.6%
Financial strength
Net profit 2024
NOK 652K
-66% vs 2023
| Revenue | NOK 525K | +18% |
| EBITDA | NOK 385K | +22% |
| Net profit | NOK 652K | -66% |
| Total assets | NOK 19M | +4% |
| Equity | NOK 18,7M | +4% |
| Employees | 0 | — |
Legal name
TER REK AS
Org number
814163792
Legal form
Aksjeselskap
NACE code
4727 · Retail sale of other food
Founded
16. september 2014
Share capital
NOK 30 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Investere i andre selskaper.
Address
Olav Selvaags Plass 4, 0252 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 181 | 306 | 420 | 446 | 525 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| EBITDA | −6 | −0 | −79 | −14 | −17 | −65 | 54 | 164 | 294 | 316 | 385 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −0 | −23 | −24 | −24 | −24 | −24 |
| EBIT | −6 | −0 | −79 | −14 | −17 | −65 | 31 | 139 | 269 | 292 | 361 |
| Net financials | 0 | 0 | 1 986 | 2 531 | 5 773 | 6 225 | 1 446 | 739 | −1 420 | 1 760 | 463 |
| Profit before tax | −6 | −0 | 1 907 | 2 517 | 5 756 | 6 160 | 1 477 | 879 | −1 151 | 2 052 | 824 |
| Tax | −0 | −0 | 0 | 1 | 7 | 33 | 58 | 186 | 75 | 127 | 172 |
| Net profit | −6 | −0 | 1 907 | 2 515 | 5 749 | 6 126 | 1 419 | 693 | −1 226 | 1 925 | 652 |
| Item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 250 | 250 | 1 859 | 4 454 | 10 205 | 15 262 | 16 717 | 17 635 | 16 230 | 18 268 | 18 957 |
| Equity | 30 | 24 | 1 931 | 4 443 | 10 178 | 15 223 | 16 642 | 17 335 | 16 110 | 18 035 | 18 687 |
| Long-term debt | 220 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 0 | 226 | −72 | 11 | 28 | 39 | 74 | 299 | 121 | 233 | 271 |
| Total debt | 220 | 226 | −72 | 11 | 28 | 39 | 74 | 299 | 121 | 233 | 271 |
EBITDA margin
73.3%
This company
15.8%
Market median
+364% vs market
20142024
Equity ratio
98.6%
This company
38.2%
Market median
+158% vs market
20142024
Return on equity
3.5%
This company
18.4%
Market median
-81% vs market
20142024
Net profit margin
124.1%
This company
8.1%
Market median
+1432% vs market
20142024
Asset turnover
0.03×
This company
1.12×
Market median
-97% vs market
20142024
Debt / equity
0.01×
This company
0.62×
Market median
+98% vs market
20142024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-09-09 – 2014-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
CH Deputy Member | Deputy Member | 2014 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2014 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
TER REK AS 
LAB PHARMA ASBoard members of TER REK AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Cybele Hoftun | Deputy Member | 0 companies |
| Haakon Ringerike Hoftun | Chairman | 0 companies |